Introduction
When retinal photoreceptors are injured by exposure to excessive light (Noell et al., 1966) , retinal damage is irreversible and leads to serious visual field loss.
Photoreceptor loss is the primary cause of blindness in degenerative diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). However, in these diseases, there are few usable therapeutic agents. To search for a candidate compound against retinal diseases, we used a light-induced photoreceptor degeneration model, and studied the mechanism of progressive disease and drug efficacy.
Calpains are calcium-activated cysteine proteases that occur during the apoptosis process (Utz and Anderson, 2000) . The calpain family is represented by 15 genes in mammals, and is comprised of two major isozymes (namely, μ -and m-calpain) which have been well-characterized (Saido et al., 1994; Evans and Turner, 2007) . The calpain family is related to many human diseases, such as Alzheimer's disease, brain ischemia, and cataracts (Huang and Wang, 2001) . Furthermore, the involvement of calpain activation was reported in retinal diseases such as glaucoma, AMD, and RP (Paquet-Durand et al., 2007; Tamada et al., 2007) . Pharmacological inhibition of calpain activation protects from retinal neuronal degeneration (Azuma and Shearer, 2008) . Therefore, calpains may be a therapeutic target for treatment of retinal disorders.
A calpain inhibitor, (2S)-4-Methyl-2-[[N-[(4-fluorophenyl) sulfonyl]-L-valyl]
amino]pentanal (SJA6017), inhibits potently calpain-1 and -2, and showed a protective effect against ischemia-reperfusion induced retinal cell death (Sakamoto et al., 2000) .
However, SJA6017 had low oral bioavailability and required high-dose administration (500 mg/kg, orally). On the other hand, a novel calpain inhibitor, This article has not been copyedited and formatted. The final version may differ from this version.
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J P E T # 1 7 1 2 9 8 5 ((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-met hylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester (SNJ-1945) was synthesized from SJA6017 (Shirasaki et al., 2005) . SNJ-1945 has more favorable retinal pharmacokinetics, such as good retinal penetration, high oral bioavailability, and long half-life (Shirasaki et al., 2006) . In our laboratory, it has been reported that SNJ-1945 has a protective effect against cerebral ischemia-induced neuronal cell death (Koumura et al., 2008) In the present study, to demonstrate the protective effects of SNJ-1945, a calpain inhibitor, against photoreceptor cell death induced by light exposure, we examined histological and electrophysiological analyses and the underlying mechanism using an in vivo mouse model. Pharmaceutical University. Male albino ddY mice (Japan SLC, Inc., Hamamatsu, Japan), aged 9 to 10 weeks, were used in this study. They were kept under controlled lighting conditions (12 h:12 h light/dark).
Exposure to Light. After dark adaptation for 24 h, the pupils were dilated with 1% cyclopentolate hydrochloride eye drops (Santen, Osaka, Japan) 30 min before exposure to light. Non-anesthetized mice were exposed to 8,000 lux of white fluorescent light (Toshiba, Tokyo, Japan) for 3 h in cages with a reflective interior. The temperature during exposure to light was maintained at 25 ± 1.5°C. After the exposure to light, all mice were returned to darkness for 24 h and then placed in the normal light/dark cycle.
Treatment with SNJ-1945. The SNJ-1945,
carbamic acid 5-methoxy-3-oxapentyl ester, was a gift from Senju Pharmaceutical Co. Ltd. (Kobe, Japan) and it was suspended in distilled water containing 0.5% carboxymethyl cellulose (CMC). SNJ-1945 was orally administrated at 100 or 200 mg/kg, or intraperitoneally administrated at 100 mg/kg, at 30 min before and just after exposure to light. The vehicle group was treated with 10 mL/kg CMC.
Electroretinogram. Electroretinograms (ERG) were recorded at 5 days after light
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exposure (Mayo, Aichi, Japan). Mice were maintained in a totally dark room for 24 h.
They were intraperitoneally anesthetized with a mixture of ketamine (120 mg/kg) (Daiichi-Sankyo, Tokyo, Japan) and xylazine (6 mg/kg) (Bayer Health Care, Tokyo, Japan). Pupils were dilated with 1% tropicamide and 2.5% phenylephrine (Santen).
Flash ERG was recorded in the left eyes of dark-adapted mice by placing a gold ring electrode (Mayo) in contact with the cornea and a reference electrode (Nihon Kohden, Tokyo, Japan) through the tongue. A neutral electrode (Nihon Kohden) was inserted subcutaneously near the tail. All procedures were performed in dim red light, and the mice were kept warm during the entire procedure. The amplitude of the a-wave was measured from the baseline to the maximum a-wave peak, and the b-wave was measured from the maximum a-wave peak to the maximum b-wave peak.
Histological Analysis. In mice under anesthesia produced by an intraperitoneal injection of sodium pentobarbital (80 mg/kg) (Nakalai Tesque, Kyoto, Japan), each eye was enucleated and kept immersed in a fixative solution containing 4%
paraformaldehyde for at least 24 h at 4°C. Six paraffin-embedded sections (thickness 5 µm) cut through the optic disc of each eye were prepared in a standard manner, and stained with hematoxylin and eosin. The damage induced by light exposure was then evaluated, with six sections from each eye being used for the morphometric analysis described below. Light-microscope images were photographed, and the thickness of the ONL from the optic disc was measured at 240 µm intervals by photograph in a masked fashion by a single observer (S.I.). Data from three sections (selected randomly from the six sections) were averaged for each eye.
This article has not been copyedited and formatted. The final version may differ from this version. Maximum Sensitivity Substrate (Pierce Biotechnology). The band intensity was measured using a Lumino Imaging Analyzer (Fujifilm, Osaka, Japan).
Caspase-3/7 Assay. In vivo, mice were euthanized using sodium pentobarbital at 80 mg/kg, i.p. and their eyeballs were quickly removed. The retinas were carefully separated from the eyeballs and quickly frozen in liquid nitrogen. For protein extraction, the tissue was homogenized in cell-lysis buffer using a homogenizer (Physcotron; Microtec Co. Ltd., Chiba, Japan). The lysate was centrifuged at 12,000×g for 20 min and the supernatant used for this study. The protein concentration was measured by comparison with a known concentration of bovine serum albumin using a BCA Protein Assay Kit (Pierce Biotechnology). Caspase-3/7
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Results

Effects of SNJ-1945 on the activation of calpain by light exposure
To investigate the activation of calpain after light exposure, proteolysis of the cytoskeletal protein α -spectrin was measured by Western blot ( Fig 
Effects of SNJ-1945 against the degradation of p35 by light exposure
To investigate calpain-induced photoreceptor degeneration, p35 (Cdk5 regulator protein) was measured in light-exposed mouse retinas. Time-dependent degradation of p35 after light exposure was shown in Fig. 2A . In non-treated normal retinas, p35
protein was expressed, and in light-exposed retinas, p35 was decreased at 48 and 72 h after light exposure; p35 was significantly reduced (Fig. 2B) . Treatment with SNJ-1945 (200 mg/kg, p.o. or 100 mg/kg, i.p.) inhibited the degradation of p35 at 48 h after light exposure (Fig 2C, D) .
Effects of SNJ-1945 on light-induced photoreceptor degeneration
In histological evaluation, Figure 3A -3E shows representative retinal images between 480 μ m to 720 μ m from the optic nerve in the superior area at 5 days after light exposure. The ONL thickness was remarkably thinned in the vehicle-treated group (Fig. 3B ) versus the non-treated normal group (Fig. 3A) . The group treated with This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 3F ).
Light-induced expression of TUNEL-positive cells
To 
Electroretinogram (ERG)
The effects of SNJ-1945 on light-induced photoreceptor degeneration were examined by electrophysiologic analyses. Both a-and b-wave amplitudes were significantly reduced at 5 days after 8,000 lux white light exposure for 3 h, and a-and b-wave decreased by 85% and 83%, respectively, as compared with non-treated retina at 0.98 log cds/m 2 (Fig. 5B, C amplitudes, when compared with the saline-treated group (Fig. 5B, C) .
Effect of SNJ-1945 against light-induced caspase-3/7 activation
We investigated the mechanism of photoreceptor degeneration and the effect of SNJ-1945. We measured time-dependent changes in caspase-3/7 activity after light exposure. Caspase-3/7 activity was increased just after light exposure, and decreased at 24 h. However, at 48 h, caspase-3/7 activity was elevated again (Fig. 6A) . At 48 h after light exposure, we investigated the effect of SNJ-1945 against light-induced caspase-3/7 activation. Systemic (oral or intraperitoneal) treatment with SNJ-1945 inhibited caspase-3/7 activity (Fig. 6B ).
Discussion
In the present study, we showed the protective effects of SNJ-1945, a novel calpain inhibitor, against light-induced retinal degeneration in mice.
As a result of light irradiation, retinal photoreceptors trigger apoptotic cell death (Abler et al., 1996) . One of the causes is elevation of intracellular calcium concentrations and calpain activation. It has been reported that intracellular calcium influx and calpain activation were increased by light exposure, and a calcium channel blocker, flunarizine, was protective from retinal damage by light exposure (Edward et al., 1991; Isayama et al., 1991; Donovan et al., 2001) . Furthermore, in other retinal degeneration models such as the retinal degeneration (rd) 1 mouse and MNU-induced retinal degeneration, calpain activation was increased in photoreceptor cells (Paquet-Durand et al., 2006; Oka et al., 2007) . In the present study, we examined calpain activation by measuring calpain-specific α-spectrin fragments at 145 kDa in mouse retina after light exposure. The 150 kDa fragments are broken by the effects of calpain and caspase-3, while the 145 kDa fragment is broken only by calpain (Nath et al., 1996) . In the retina, α-spectrin is localized in inner and outer retina (Isayama et al., 1991) , and the proteolysis of spectrin is thought to be a cause of retinal cell death. We showed that the cleaved products of α-spectrin at 145 kDa increased at 24 h after light administration of SNJ-1945 at 100 mg/kg is predicted to be higher than that after the oral administration at 100 mg/kg, and the half-life is shorter than that. Therefore, it is considered that SNJ-1945 at 100 mg/kg, i.p., but not at 100 mg/kg, p.o., was effective in the ONL atrophy after light exposure.
Retinal diseases in human and animal models lead to apoptotic cell death (Nickells and Zack, 1996; Reme et al., 2000) and, in light-induced retinal degeneration, apoptosis During apoptosis processes, caspase-3 has been identified as a key protease in the execution of apoptosis, whereas calpains have been implicated in neuronal death (Blomgren et al., 2001) . In both inherited retinal degeneration and light-induced retinal degeneration, caspase-3 inhibitors showed a protective effect, suggesting that photoreceptor degeneration is related to caspase-3 activation (Perche et al., 2007; Perche et al., 2008) . For these reasons, we confirmed that caspase-3/7 was activated by light injury, being significant at 48 h after light exposure. Costa et al. (2008) also reported that caspase-3 was up-regulated at 48 h after light exposure, and our result corresponded with those results. In the present study, SNJ-1945 inhibited caspase-3/7
activation at 48 h after light exposure. Taken together, these results suggest that caspase-3 activation is partially mediated by calpain activation after light exposure.
However, we do not have any data about specificity of SNJ-1945 against calpain. solubility (Shirasaki et al., 2006) . SJA-6017 is well known to inhibit cathepsin B and L in addition to calpain, but does not inhibit other cysteine proteases (interleukin 1β converting enzyme), serine proteases (trypsin, chymotrypsin, thrombin, factor VIIa, factor Xa), or proteasome (Inoue et al., 2003) . Furthermore, a docking study supported that SNJ-1945 bound in the active site pocket of µ-calpain (Azuma and Shearer, 2008) . Accordingly, SNJ-1945 is also predicted to have similar profiles with SJA-6017, but further studies will be needed.
In conclusion, we demonstrated that SNJ-1945, a calpain inhibitor, has neuroprotective effects against light-induced retinal damage. SNJ-1945 may be a candidate compound for photoreceptor degeneration-related diseases.
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